Research Progress on the Treatment of Adenomyosis-Related Pain with Dienogest
YAN Ying
YANG Yang
ZHONG Hua
LIANG Yan-chun
Abstract：Dysmenorrhea is one of the main symptoms of adenomyosis(AM).The pathogenesis of AM-related pain involves multiple mechanisms.Dienogest,as one of the key drugs for the treatment of AM-related pain,plays an important role in the long-term management of AM.Basic research shows that dienogest can achieve the goals of reducing inflammation,decreasing pain hypersensitivity,and controlling the progression of AM through multiple mechanisms of action,such as inhibiting the proliferation and inflammatory response of ectopic endometrial stromal cells,promoting apoptosis,regulating the expression of nerve growth factors and the immune microenvironment,and inhibiting angiogenesis.Clinical research evidence further clarifies that dienogest is more effective than other drugs in relieving AM-related pain,improving uterine bleeding,and controlling uterine volume.It can be used as a long-term treatment drug for AM-related pain,providing a scientific basis for further in-depth research on the mechanism of action and clinical application of dienogest.
Keywords：AdenomyosisPainTherapyPain managementDienogest
Publication Date：2025-06-15
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：6( 246-251 )